* Cardio Diagnostics Holdings Inc CDIO.OQ reported a
quarterly
adjusted loss of 20 cents per share for the quarter ended in
March, lower than the same quarter last year, when the company
reported EPS of -11 cents. The mean expectation of two analysts
for the quarter was for a loss of 9 cents per share. Wall Street
expected results to range from -10 cents to -8 cents per share.
* Revenue was $15.93 thousand; analysts expected $50.00
thousand.
* Cardio Diagnostics Holdings Inc's reported EPS for the
quarter
was a loss of 20 cents.
* The company reported a quarterly loss of $4.16 million.
* Cardio Diagnostics Holdings Inc shares had fallen by 40.9%
this
quarter and lost 66.3% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 37.9%
in the last three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"
Wall Street's median 12-month price target for Cardio
Diagnostics Holdings Inc is $4.68
This summary was machine generated from LSEG data May 17 at
09:01 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.09 -0.20 Missed
Dec. 31 2023 -0.13 0.00 Beat
Sep. 30 2023 -0.27 -0.16 Beat
Jun. 30 2023 -0.18 -0.39 Missed